drugset / Trial / NCT05555290

PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction

NCT05555290

Phase 3 Completed 190 enrolled AstraZeneca
RandomizedCrossoverQuadruple-blindTreatment

Summary

A study evaluating efficacy and safety of repeated doses of PT027 compared to PT007 in patients with asthma and acute airway obstruction induced by repeated mannitol challenges

Timeline

Start
2022-09-28
Primary completion
2024-11-18
Completion
2024-11-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Inhaled
Background Salbutamol Unknown Inhaled

Indications